Cardiovascular-kidney-metabolic syndrome stage predicts cardiovascular outcomes in cancer patients: a real-world data analysis of a nationwide epidemiological dataset

The CKM staging system effectively stratifies cardiovascular risk in cancer patients, with higher stages predicting significantly worse outcomes. These findings advocate for integrating CKM assessment into onco-cardiologic practice to guide early intervention and improve patient outcomes.

Authors

Institutions

Publication Details

Journal
European Heart Journal Open
Published
2025-08-28
DOI
https://doi.org/10.1093/ehjopen/oeaf115
Primary Topic
Chemotherapy-induced cardiotoxicity and mitigation
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Cardiovascular-kidney-metabolic syndrome stage predicts cardiovascular outcomes in cancer patients: a real-world data analysis of a nationwide epidemiological dataset

Norihiko Takeda, Yuta Suzuki, Hidehiro Kaneko, Hiroyuki Morita et al.
European Heart Journal Open
Chemotherapy-induced cardiotoxicity and mitigation
article

Cardiovascular-kidney-metabolic syndrome stage predicts cardiovascular outcomes in cancer patients: a real-world data analysis of a nationwide epidemiological dataset

Norihiko Takeda, Yuta Suzuki, Hidehiro Kaneko, Hiroyuki Morita, Norifumi Takeda, Katsuhito Fujiu, Masaomi Nangaku, Kaori Hayashi, Takahiro Jimba, Koichi Node, Akira Okada, Kentaro Ejiri, Hideo Yasunaga, Tatsuhiko Azegami, Toshiyuki Ko, Atsushi Mizuno
article en

Abstract

The CKM staging system effectively stratifies cardiovascular risk in cancer patients, with higher stages predicting significantly worse outcomes. These findings advocate for integrating CKM assessment into onco-cardiologic practice to guide early intervention and improve patient outcomes.

European Heart Journal OpenVol. 5(5)
Okayama University (JP), Saga University (JP), Keio University (JP), St. Luke's International Hospital (JP), National Institute of Public Health (JP), Keio University Hospital (JP), University of Tokyo Health Sciences (JP), Department of Health (IE), The University of Tokyo (JP)
Japan Foundation for Applied Enzymology, Uehara Memorial Foundation, Ministry of Education, Culture, Sports, Science and Technology, Ministry of Health, Labour and Welfare, Daiichi Sankyo Foundation of Life Science, SENSHIN Medical Research Foundation, Japan Heart Foundation, Japan Society for the Promotion of Science, Daiichi Sankyo Europe
Openalex Percentile: Top 65%
Chemotherapy-induced cardiotoxicity and mitigation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.